PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0518
    The translation of the content is as follows: Standardize the collection and application of cord blood from premature babies. It has been proven that: 1. Cord blood gas analysis of newborns can provide information about fetal ischemia and hypoxia; 2. Cord blood culture and detection of cytokines can predict early-onset sepsis in newborns; 3. The use of cord blood for prevention and treatment of complications in premature infants has been proven to be safe and potentially effective.
  • 2024.0518
    Multiple organ dysfunction syndrome in the elderly (MODSE) refers to a syndrome in which an elderly person (≥ 65 years old), comorbid with organ aging and multiple chronic diseases, experiences sequential or simultaneous dysfunction or failure of two or more organs 24 hours later after infection, trauma, and major surgery. It has a mortality rate of over 75%. Infection, especially lung and urinary tract infections, is the primary cause of MODSE. Infection induced multiple organ dysfunction syndrome (i-MODSE) is common among elderly patients with diverse clinical manifestations and significant individual differences. It lacks epidemiological data and evidence-based diagnosis and treatment information, leading to a difficult point in the severe elderly diseases. As early as 2000, the team of Academician Wang Shiwen came up with the "lung activation theory" for MODSE and formulated China's first diagnostic standard for MODSE (trial draft) in 2003. In 2018 and 2019, under the joint efforts of domestic multidisciplinary experts, the Chinese Geriatrics Society and the National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital) successively issued China's first "Chinese Expert Consensus on the Diagnosis and Treatment of Infection-induced Elderly Multiple Organ Dysfunction Syndrome" [10] and "Chinese Guidelines for the Diagnosis and Treatment of Infection-induced Elderly Multiple Organ Dysfunction Syndrome 2019", It provides evidence-based recommendations for the diagnosis, evaluation, and management of i-MODSE. In 2021, the team also issued special diagnosis and treatment expert recommendations on i-MODSE induced by novel coronavirus pneumonia. The aforementioned i-MODSE consensus, guidelines, and expert recommendations have played a positive role in improving the scientificity and standardization of clinical decision-making for the management of i-MODSE. In recent years, with the continuous increase of new evidence-based evidence in this field and the updating of related diagnostic and treatment concepts, the existing guidelines is unable to guide clinical practice in a better way. Therefore, it is imperative to update the i-MODSE diagnostic and treatment guidelines in a timely manner. To update the "Chinese Guidelines for the Diagnosis and Treatment of Infection-induced Multiple Organ Dysfunction Syndrome in the Elderly 2024" (hereinafter referred to as this guideline) and combine with clinical practice in China, the guideline development team has strictly followed the methods and steps of developing evidence-based clinical practice guidelines based on the latest research evidence.
Registration process and operational mode of a CPG registry